Back to Results
First PageMeta Content
Oncotype DX / HER2/neu / Biomarker / Anatomical pathology / Cancer / Breast cancer / Medicine / Pathology / Oncology


AHS Laboratory Services Client Resource TM Oncotype Dx Testing and Reporting - Oncologist Effective Date: March 17, 2014
Add to Reading List

Document Date: 2014-05-08 18:22:53

Open Document

File Size: 95,87 KB

Share Result on Facebook

City

Edmonton / Redwood City / Calgary / /

Company

Biomarker Laboratory / Original Biomarker Testing Laboratory / University Avenue Edmonton AB / CCI / Biomarker Laboratories / Anatomical Pathology Laboratory / Genomic Health Inc. / Lougheed Center 3500 26 Avenue NE Calgary AB / /

Country

United States / /

Event

FDA Phase / /

Facility

Biomarker Laboratory / /

/

MedicalCondition

Cancer / HER2negative early breast cancer / heterogeneous disease / Background Breast cancer / /

MedicalTreatment

adjuvant chemotherapy / endocrine therapy / chemotherapy / /

Organization

Lamont Health Centre / BM Lab / Department of Pathology / Peter Lougheed Center / Edmonton Zone IHC Lab / /

/

Position

BM Pathologist / Provincial Head / Ordering BM Pathologist / requesting physician / ORDERING PHYSICIAN / /

Product

Request / Ki67 / /

ProvinceOrState

Alberta / /

Technology

Gene expression / chemotherapy / *ODx protocol / /

URL

http /

SocialTag